Patents by Inventor Donald Hopper

Donald Hopper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210093215
    Abstract: Computer implemented methods and systems are provided that comprise, under control of one or more processors of a medical device, where the one or more processors are configured with specific executable instructions. The methods and systems obtain motion data indicative of at least one of a posture or a respiration cycle; obtain cardiac activity (CA) signals for a series of beats; identify whether a characteristic of interest (COI) from at least a first segment of the CA signals exceeds a COI limit; analyze the motion data to determine whether at least one of the posture or respiration cycle at least in part caused the COI to exceed the COI limit. Based on the analyzing operation, the methods and systems automatically adjust a CA sensing parameter utilized by the medical device to detect R-waves in subsequent CA signals; and detect an arrhythmia based on a presence or absence of one or more of the R-waves in at least a second segment of the CA signals.
    Type: Application
    Filed: October 1, 2019
    Publication date: April 1, 2021
    Inventors: Donald Hopper, Luke C. McSpadden, Fujian Qu, Gene Bornzin, Sinny Delacroix
  • Patent number: 9079033
    Abstract: Changes in patient status are assessed based at least in part on respiration parameters. A user can make selections regarding alert criteria options to be used in assessing patient status. Respiration is implantably sensed and respiration data is stored by an implantable device. A respiration parameter, such as respiration rate, is measured from the respiration data. The change in patient status is assessed by comparing the respiration parameter to the configured alert criteria. If the comparison of the respiration parameter and the configured alert criteria indicates a significant change in patient status, an alert signal is generated.
    Type: Grant
    Filed: January 20, 2009
    Date of Patent: July 14, 2015
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Richard O. Kuenzler, Donald Hopper, Mary Jane Rasmussen, Aaron McCabe, John Layton
  • Patent number: 8463380
    Abstract: Methods and systems to modulate timing intervals for pacing therapy are described. For each cardiac cycle, one or both of an atrioventricular (A-V) timing interval and an atrial (A-A) timing interval are modulated to oppose beat-to-beat ventricular (V-V) timing variability. Pacing therapy is delivered using the modulated timing intervals.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: June 11, 2013
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Donald Hopper, Yinghong Yu, Allan C. Shuros, Shantha Arcot-Krishnamurthy, Gerrard M. Carlson, Jeffrey E. Stahmann
  • Patent number: 8311631
    Abstract: Adaptive rate pacing for improving heart rate kinetics in heart failure patients involves determining onset and sustaining of patient activity. The patient's heart rate response to the sustained activity is evaluated during a time window defined between onset of the activity and a steady-state exercise level. If the patient's heart rate response to the sustained activity is determined to be slow, a pacing therapy is delivered at a rate greater than the patient's intrinsic heart rate based on a profile of the patient's heart rate response to varying workloads. If determined not to be slow, the pacing therapy is withheld. Monitoring-only configurations provide for acquisition and organization of physiological data for heart failure patients. These data can be acquired on a per-patient basis and used to assess the HF status of the patient.
    Type: Grant
    Filed: August 21, 2009
    Date of Patent: November 13, 2012
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Donald Hopper, Yinghong Yu, Yanting Dong
  • Patent number: 8290587
    Abstract: System and methods provide pacing therapy that modulates the atrioventricular (AV) delay to control ventricular interval variability. A base AV delay is determined as a function of heart rate. For each cardiac cycle, the base AV delay is modulated to reduce beat-to-beat variability of successive ventricular beats. The modulated AV delay compensates for variability of successive atrial beats. For example, modulation of the base AV delay may involve varying the AV delay inversely with a change in atrial interval.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: October 16, 2012
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Barun Maskara, Donald Hopper, Yinghong Yu
  • Publication number: 20120004696
    Abstract: A system and method for automatically adjusting the operating parameters of a rate-adaptive cardiac pacemaker. In accordance with the method, maximum exertion levels attained by the patient are measured at periodic intervals and stored. The stored maximum exertion levels may then be used to update a long-term maximal exertion level, and the slope of the rate-response curve is adjusted to map the updated long-term maximal exertion level to a maximum allowable pacing rate. The stored maximum exertion levels may also be used to update a sensor target rate which is used to adjust the slope of the rate response curve.
    Type: Application
    Filed: September 12, 2011
    Publication date: January 5, 2012
    Inventors: Weimin Sun, Bruce R. Jones, Douglas J. Lang, Donald Hopper
  • Patent number: 7869877
    Abstract: An implantable cardiac device is configured and programmed to assess a patient's cardiopulmonary function by evaluating the patient's heart rate response. Such evaluation may be performed by computing a heart rate response slope, defined as the ratio of an incremental change in intrinsic heart rate to an incremental change in measured activity level. The heart rate response slope may then be compared with a normal range to assess the patient's functional status.
    Type: Grant
    Filed: September 10, 2007
    Date of Patent: January 11, 2011
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Veerichetty Kadhiresan, Donald Hopper, Richard Fogoros, Lemont Baker
  • Publication number: 20090299159
    Abstract: An implantable device monitors the balance between sympathetic tone and parasympathetic tone as a function of an activity level. Cardio-neurological healthy users exhibit a generally sympathetic tone in conjunction with heavy activity level and a generally parasympathetic tone in conjunction with periods of low activity level. Deviations from expected results are associated with a health problem. Measured conditions are stored and available for subsequent reporting to a remote programmer. Therapy delivered by an implantable device is determined as a function of the relationship between autonomic balance and activity level.
    Type: Application
    Filed: August 10, 2009
    Publication date: December 3, 2009
    Inventors: Avram Scheiner, Donald Hopper, Gerrard M. Carlson
  • Publication number: 20090234240
    Abstract: Changes in patient status are assessed based at least in part on respiration parameters. A user can make selections regarding alert criteria options to be used in assessing patient status. Respiration is implantably sensed and respiration data is stored by an implantable device. A respiration parameter, such as respiration rate, is measured from the respiration data. The change in patient status is assessed by comparing the respiration parameter to the configured alert criteria. If the comparison of the respiration parameter and the configured alert criteria indicates a significant change in patient status, an alert signal is generated.
    Type: Application
    Filed: January 20, 2009
    Publication date: September 17, 2009
    Inventors: Richard O. Kuenzler, Donald Hopper, Mary Jane Rasmussen, Aaron McCabe, John Layton
  • Patent number: 7572226
    Abstract: An implantable device monitors the balance between sympathetic tone and parasympathetic tone as a function of an activity level. Cardio-neurological healthy users exhibit a generally sympathetic tone in conjunction with heavy activity level and a generally parasympathetic tone in conjunction with periods of low activity level. Deviations from expected results are associated with a health problem. Measured conditions are stored and available for subsequent reporting to a remote programmer. Therapy delivered by an implantable device is determined as a function of the relationship between autonomic balance and activity level.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: August 11, 2009
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Avram Scheiner, Donald Hopper, Gerrard M. Carlson
  • Patent number: 7567839
    Abstract: A system and method for automatically adjusting the operating parameters of a rate-adaptive cardiac pacemaker. In accordance with the method, maximum exertion levels attained by the patient are measured at periodic intervals and stored. The stored maximum exertion levels may then be used to update a long-term maximal exertion level, and the slope of the rate-response curve is adjusted to map the updated long-term maximal exertion level to a maximum allowable pacing rate. The stored maximum exertion levels may also be used to update a sensor target rate which is used to adjust the slope of the rate response curve.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: July 28, 2009
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Weimin Sun, Bruce R. Jones, Douglas J. Lang, Donald Hopper
  • Publication number: 20090132000
    Abstract: A system receives signals indicative of cardiopulmonary conditions sensed by a plurality of sensors and provides for monitoring and automated differential diagnosis of the cardiopulmonary conditions based on the signals. Cardiogenic pulmonary edema is detected based on one or more signals sensed by implantable sensors. If the cardiogenic pulmonary edema is not detected, obstructive pulmonary disease and restrictive pulmonary disease are each detected based on a forced vital capacity (FVC) parameter and a forced expiratory volume (FEV) parameter measured from a respiratory signal sensed by an implantable or non-implantable sensor. In one embodiment, an implantable medical device senses signals indicative of the cardiopulmonary conditions, and an external system detects the cardiopulmonary conditions based on these signals by executing an automatic detection algorithm.
    Type: Application
    Filed: January 8, 2009
    Publication date: May 21, 2009
    Applicant: Cardiac Pacemakers, Inc.
    Inventors: Marina Brockway, Donald Hopper, Gerrard M. Carlson, Veerichetty Kadhiresan, Kenneth Beck
  • Patent number: 7480528
    Abstract: A system receives signals indicative of cardiopulmonary conditions sensed by a plurality of sensors and provides for monitoring and automated differential diagnosis of the cardiopulmonary conditions based on the signals. Cardiogenic pulmonary edema is detected based on one or more signals sensed by implantable sensors. If the cardiogenic pulmonary edema is not detected, obstructive pulmonary disease and restrictive pulmonary disease are each detected based on a forced vital capacity (FVC) parameter and a forced expiratory volume (FEV) parameter measured from a respiratory signal sensed by an implantable or non-implantable sensor. In one embodiment, an implantable medical device senses signals indicative of the cardiopulmonary conditions, and an external system detects the cardiopulmonary conditions based on these signals by executing an automatic detection algorithm.
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: January 20, 2009
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Marina Brockway, Donald Hopper, Gerrard M. Carlson, Veerichetty Kadhiresan, Kenneth Beck
  • Patent number: 7389143
    Abstract: An implantable cardiac device is configured and programmed to assess a patient's cardiopulmonary function by evaluating the patient's minute ventilation response. Such evaluation may be performed by computing a minute ventilation response slope, defined as the ratio of an incremental change in minute ventilation to an incremental change in measured activity level. The minute ventilation response slope may then be compared with a normal range to assess the patient's functional status.
    Type: Grant
    Filed: August 12, 2004
    Date of Patent: June 17, 2008
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Donald Hopper, Bruce Wilkoff, Richard Morris
  • Publication number: 20080004668
    Abstract: An implantable cardiac device is configured and programmed to assess a patient's cardiopulmonary function by evaluating the patient's heart rate response. Such evaluation may be performed by computing a heart rate response slope, defined as the ratio of an incremental change in intrinsic heart rate to an incremental change in measured activity level. The heart rate response slope may then be compared with a normal range to assess the patient's functional status.
    Type: Application
    Filed: September 10, 2007
    Publication date: January 3, 2008
    Applicant: Cardiac Pacemakers, Inc.
    Inventors: Veerichetty Kadhiresan, Donald Hopper, Richard Fogoros, Lemont Baker
  • Patent number: 7269458
    Abstract: An implantable cardiac device is configured and programmed to assess a patient's cardiopulmonary function by evaluating the patient's heart rate response. Such evaluation may be performed by computing a heart rate response slope, defined as the ratio of an incremental change in intrinsic heart rate to an incremental change in measured activity level. The heart rate response slope may then be compared with a normal range to assess the patient's functional status.
    Type: Grant
    Filed: August 9, 2004
    Date of Patent: September 11, 2007
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Veerichetty Kadhiresan, Donald Hopper, Richard Fogoros, Lemont Baker
  • Publication number: 20070021678
    Abstract: This document discusses, among other things, methods of monitoring physiological responses to steady state activity. In an example, a physical activity signal is detected from a human or animal subject using an implantable medical device. A different, other physiological signal is also detected from the subject using the implantable medical device. The physical activity signal is processed to define first and second time periods associated with first and second steady-state physical activity levels of the subject. A first indicator is obtained by combining data from the other physiological signal obtained during the first time period. A second indicator is obtained by combining data from the other physiological signal obtained during the second time period. The first and second indicators are used provide a diagnostic indicator.
    Type: Application
    Filed: July 19, 2005
    Publication date: January 25, 2007
    Inventors: Kenneth Beck, Lemont Baker, Donald Hopper
  • Patent number: 7142920
    Abstract: An implantable cardiac device with an exertion level sensor is programmed to determine a heart rate appropriate for a given measured exertion level in accordance with a physiological model and/or previously collected physiologic data. The device then compares the model's heart rate with a measured intrinsic heart rate. Based upon this data, the device is able to recognize changes in the patient's heart rate response and predict or recognize a chronotropically incompetent condition.
    Type: Grant
    Filed: May 25, 2004
    Date of Patent: November 28, 2006
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Avram Scheiner, Donald Hopper
  • Publication number: 20060247704
    Abstract: A system and method for automatically adjusting the operating parameters of a rate-adaptive cardiac pacemaker. In accordance with the method, maximum exertion levels attained by the patient are measured at periodic intervals and stored. The stored maximum exertion levels may then be used to update a long-term maximal exertion level, and the slope of the rate-response curve is adjusted to map the updated long-term maximal exertion level to a maximum allowable pacing rate. The stored maximum exertion levels may also be used to update a sensor target rate which is used to adjust the slope of the rate response curve.
    Type: Application
    Filed: July 13, 2006
    Publication date: November 2, 2006
    Inventors: Weimin Sun, Bruce Jones, Douglas Lang, Donald Hopper
  • Publication number: 20060195149
    Abstract: Cardiac monitoring and/or stimulation methods and systems employing dyspnea measurement. An implantable cardiac device may sense transthoracic impedance and determine a patient activity level. An index indicative of pulmonary function is implantably computed to detect an episode of dyspnea based on a change, trend, and/or value exceeding a threshold at a determined patient activity level. Trending one or more pulmonary function index values may be done to determine a patient's pulmonary function index profile, which may be used to adapt a cardiac therapy. A physician may be automatically alerted in response to a pulmonary function index value and/or a trend of the patient's pulmonary index being beyond a threshold. Computed pulmonary function index values and their associated patient's activity levels may be stored periodically in a memory and/or transmitted to a patient-external device.
    Type: Application
    Filed: February 28, 2005
    Publication date: August 31, 2006
    Inventors: Donald Hopper, John Voegele, Jesse Hartley, Avram Scheiner